Development of New Prenatal Diagnostic Tests From Maternal Blood

NCT ID: NCT00314691

Last Updated: 2011-07-28

Basic Information

• Recruitment Status: TERMINATED
• Clinical Phase: NA
• Total Enrollment: 10 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2006-04-30
• Study Completion Date: 2006-09-30

Brief Summary

After extraction of the cell-free DNA circulating in maternal plasma, we aim at developing new techniques for fetal DNA enrichment to perform fetal gender determination, and indirect diagnosis of inherited diseases like Cystic Fibrosis, Huntington Disease, Myotonic Dystrophy, B-Thalassaemia...

Conditions

Hereditary Diseases

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: DIAGNOSTIC
• Blinding Strategy: NONE

Interventions

Blood samples

Intervention Type: GENETIC

Eligibility Criteria

Inclusion Criteria

• Mother and father-to-be both older than 18 years old
• Mother and father-to-be affiliated to social security
• Mother and father-to-be have good understanding of the protocol
• Pregnancy of the mother-to-be attested

Exclusion Criteria

• Mother and father-to-be are younger than 18 years old
• Mother and/or father-to be refusing to participate

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

University Hospital, Strasbourg, France

OTHER

Sponsor Role: lead

Principal Investigators

Romain FAVRE, MD

Role: PRINCIPAL_INVESTIGATOR

SIHCUS-CMCO de Schiltigheim, Strasbourg, FRANCE

Locations

Sihcus-Cmco

Strasbourg, Schiltigheim, France

Countries

France

Other Identifiers

3612

Identifier Type: -

Identifier Source: org_study_id